验证数据展示
经过测试的应用
Positive IP detected in | HEK-293 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
KD/KO | See 1 publications below |
WB | See 4 publications below |
产品信息
18298-1-AP targets BMF in WB, IP, ELISA applications and shows reactivity with human samples.
经测试应用 | IP, ELISA Application Description |
文献引用应用 | WB |
经测试反应性 | human |
文献引用反应性 | human, mouse |
免疫原 | Peptide 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | Bcl2 modifying factor |
别名 | FLJ00065, Bcl-2-modifying factor |
计算分子量 | 21 kDa |
观测分子量 | 24 kDa |
GenBank蛋白编号 | BC069505 |
基因名称 | BMF |
Gene ID (NCBI) | 90427 |
RRID | AB_2259162 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q96LC9 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
BMF belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities such as central regulators of apoptotic cell death. BMF contains a single BCL2 homology domain 3 (BH3), and has been shown to bind BCL2 proteins and function as an apoptotic activator. This protein is found to be sequestered to myosin V motors by its association with dynein light chain 2, which may be important for sensing intracellular damage and triggering apoptosis. Alternatively spliced transcript variants encoding different isoforms have been identified. BMF is widely expressed in tissues such as pancreas, liver and kidney, and in hematopoietic tissues.
实验方案
Product Specific Protocols | |
---|---|
IP protocol for BMF antibody 18298-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Int J Biol Sci RBMS2 Chemosensitizes Breast Cancer Cells to Doxorubicin by Regulating BMF Expression.
| ||
PLoS One Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli. | ||
Aging Dis BMF-AS1/BMF Promotes Diabetic Vascular Calcification and Aging both In Vitro and In Vivo |